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Introduction
Lung cancer is one of the most commonly diagnosed malignancies in the world, accounting for 17.6% (1.18 million people) of worldwide cancer-related deaths annually. 1 In China, national death survey and cancer registration data shows that lung cancer is also the leading cause of cancer death in most Chinese cities. 2 Lung cancer is indeed a major global public health challenge. However, to date, the precise mechanisms of lung carcinogenesis are still not fully understood. A previous study showed that low-penetrance susceptibility genes in combination with environmental factors were of importance in lung cancer development and contributed to lung cancer risk. 3 Therefore, further studies in this field could lead to better understanding of lung cancer risk and susceptibility genes.
Toward this end, our research focuses on murine double minute-2 (MDM2), which is a negative regulator of p53 tumor suppressor. MDM2 protein functions as an E3 ubiquitin ligase that recognizes the N-terminal transactivation domain of p53 protein, and inhibitor of p53 transcriptional activation. MDM2 protein plays an important role in regulation of p53 pathway activity. A single nucleotide polymorphism (SNP) of MDM2-rs2279744 was identified as a functional SNP with a T-to-G transversion and has been proven to increase the affinity of the transcriptional activator Sp1 and lead to expression of higher MDM2 messenger ribonucleic acid (mRNA) and protein levels, subsequently attenuating p53 pathway activity. 4 The elevated levels of MDM2 protein in carriers of the G-allele will inhibit the p53-induced apoptotic responses to DNAdamage, thereby resulting in genetic instability (such as gene mutations in the cells) and eventually leading to tumorigenesis at a young age. 5 However, the association between MDM2-rs2279744 SNP and lung cancer risk seems plausible; for example, Hu et al. 6 and Pine et al. 7 reported that there was no significant association between MDM2 SNP309 variant genotypes and lung cancer risk, whereas studies conducted by Zhang et al. 8 and Lind et al. 9 showed that the G-allele in the MDM2 promoter was associated with a higher lung cancer risk. Additionally, Chua et al. showed that the T-allele in the MDM2 promoter increased lung cancer risk. 10 Other studies have demonstrated that MDM2-rs2279744 SNP is associated with lung cancer risk at an early age. 11, 12 Thus, this case-control study investigated this functionally important MDM2-rs2279744 SNP in our hospital for association with lung cancer risk, together with other clinicopathological and epidemiologic data from lung cancer patients, as other factors, such as sociodemographic information, medical and family history, and lifestyle data, may also play a role in lung carcinogenesis. [13] [14] [15] [16] [17] [18] [19] Patients and methods
Study population
The study was approved by the Ethics Committee of the First Hospital of Jilin Medical University, and conducted according to the Declaration of Helsinki Principles. All subjects signed a written informed consent form. This hospital-based casecontrol study recruited a total of 1000 subjects from Northeastern China between January 2010 and December 2012. Patients who met the following criteria were included in the study: (i) a minimum of 18 years of age; (ii) primary lung cancer confirmed by pathology; (iii) Han descent; (iv) reside in Northeastern China for at least 10 years; and (v) no radiotherapy or chemotherapy performed before blood withdrawal. Patients with any of the following conditions were excluded: (i) secondary (metastatic) lung cancer; (ii) double or multiple primary cancers; and (iii) relapse after operation. Healthy controls had no cancer history within five years of the interview date. These healthy controls were randomly selected individuals who received routine physical examinations in our hospital and were matched to cases by age, gender, and residential area.
Diagnostic criteria and data collection
Standardized interviews were conducted by well-trained interviewers at either the hospital or at the homes of the studied subjects. Sociodemographic information, medical and family history, lifestyle data, and cancer diagnosis were recorded (Table 1) . Risk factors and peripheral blood lymphocytes were collected for the time prior and up to the index date (i.e. the time of diagnosis for cases and the interview date for controls). However, there were no data available on exposure to asbestos for analysis.
Genotyping and quality control
Genomic DNA was extracted from the peripheral blood lymphocytes of all subjects. MassArray (Sequenom, Inc., San Diego, CA, USA) was used for genotyping all markers by using allele specific matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. Primers and multiplex reactions were designed using the RealSNP.com website. All lung cancer patients and healthy controls were genotyped for MDM2-rs2279744 polymorphisms. Concordance among the three genomic control DNA samples presented in duplicate was 100%. Of SNPs with genotyping data, the call rate was >95%.
Statistical analysis
The Hardy-Weinberg equilibrium was performed to analyze the balance of case and control using a goodness-of-fit chisquare (χ 2 ) test. The univariate χ 2 test was used to determine genotype frequencies with observed genotype frequencies in healthy controls versus lung cancer cases and association between MDM2-rs2279744 SNP and clinicopathological data from lung cancer patients. Multivariate logistic regression analysis was used to assess the association between risk factors (SNPs were included) and lung cancer risk. All categorical variables were set as dummy variables. The first category of each environmental variable was selected as the baseline, as well as the low-risk allele of each locus. All analysis was conducted using SPSS v19.0 software (SPSS, Inc., Chicago, IL, USA). A p-value of less than 0.05 was considered statistically significant.
Results
Univariate analysis of MDM2-rs2279744 polymorphism for association with lung cancer risk A total of 1000 subjects (i.e. 500 incident lung cancer cases and 500 healthy controls) were recruited for genotyping of MDM2-rs2279744. Univariate analysis revealed that lung cancer occurred more frequently in individuals with a family history of cancer, history of chronic obstructive pulmonary disease (COPD), pulmonary tuberculosis, pneumonia, low body mass index (BMI), tobacco smoking, occupational exposure to pesticides, gasoline, or diesel, and exposure to cooking emissions, as well as a low education level (Table 1) .
Furthermore, our data also showed that the genotype distribution of MDM2-rs2279744 polymorphism was followed by Hardy-Weinberg equilibrium (P > 0.05). MDM2 G/G genotype occurred in 25.8%, G/T genotype in 48.8%, and T/T genotype in 25.4% of lung cancer cases, with a similar distribution in the healthy control (P > 0.05). Univariate analysis showed that when comparing G/G with T/T + T/G genotypes, the G/G had a tendency toward a higher incidence of lung cancer in the recessive model (P = 0.043; Table 2 ). However, there were no significant differences in the dominant, additive, or multiplicative models. 
Multivariate analysis of MDM2-rs2279744 polymorphism for association with lung cancer risk
Multivariate analysis showed a significantly increased lung cancer risk in individuals with a lower education level, lower BMI, cancer family history, prior diagnosis of COPD and pneumonia, exposure to pesticide or gasoline/diesel, tobaccco smoking, heavy cooking smoke, and MDM2-rs2279744 SNP. The latter was still a significant risk factor for lung cancer, even after incorporating environmental and lifestyle factors ( Table 3) .
Association of MDM2-rs2279744 SNP with clinicopathological patient data
We also evaluated MDM2-rs2279744 SNP for association with the clinicopathological data from lung cancer patients.
We did not find any statistically significant associations (Table 4) .
Discussion
Several study models have been developed to predict the individual risk for lung cancer using patient characteristics, epidemiologic, social, and clinical risk factors. [13] [14] [15] [16] [17] [18] [19] Our current study genotyped MDM2-rs2279744 SNP in a Northeastern Chinese population to associate lung cancer risk, together with other clinicopathological and epidemiologic factors. We found that there were several factors associated with lung cancer risk, including family history of cancer, COPD, pneumonia, occupational exposure to pesticide or gasoline/diesel, duration of tobacco smoking, and heavy cooking smoke, as well as lower education level or BMI. Our current data are consistent with the findings of previous studies. [13] [14] [15] [16] [17] [18] [19] Furthermore, our current study also showed that the MDM2-rs2279744 G/G genotype was associated with lung cancer risk in recessive model analysis and was still associated with lung cancer risk after incorporating environmental and lifestyle factors. Thus, this study has demonstrated that the MDM2-rs2279744 G/G genotype is associated with lung cancer risk. Molecularly, MDM2-rs2279744 is a functional SNP and is able to regulate MDM2 protein expression, that is, the MDM2-rs2279744 G-allele results in higher levels of MDM2 mRNA and protein, which, in turn, attenuate the p53 stress response pathway through directly blocking p53 transcriptional activity and mediating p53 protein degradation. 4, 20 The attenuation of p53 pathway activity will lead to lung carcinogenesis, which has been confirmed in an animal experiments, that is, suppression of the p53 pathway increased the lung tumor multiplicity in p53-mutated mice after they were exposed to tobacco smoke. 21, 22 A predisposition to cancer has been presented in MDM2 overexpressed mice. 23 Furthermore, MDM2-rs2279744 SNP was not associated with any clinicopathological data from lung cancer patients. This was a surprising result, but mechanistically it may be rationalized that p53 expression is a result of p53 mutations in most lung cancers. In this case, the p53 gene pathway was already altered and the increased MDM2 expression as a result of MDM2-rs2279744 G/G SNP did not contribute to tumor progression. Indeed, in previous studies, the p53 rs1042522 C-allele SNP was associated with reduced apoptotic potential in lung cancer patients compared to the p53 G-allele, and might modulate lung cancer risk, cancer progression, and/or response to treatment, [24] [25] [26] indicating that p53 plays an important role in the suppression of lung carcinogenesis.
There were a number of limitations in our study. Firstly, the MDM2-TP53 interaction played a pivotal role in regulation of the cell-cycle checkpoint, DNA repair, and apoptotic cell death. A common SNP at p53 rs1042522 has also been found to be of functional significance, with the C-allele having reduced the apoptotic potential compared to the G-allele, which may modulate the lung cancer risk, progression, and/or response to treatment. [24] [25] [26] Our current data would be much stronger in the prediction of lung cancer risk if we would combine this p53 SNP with MDM2-rs2279744 G/G SNP. Secondly, our current data may not be generalizable to other populations because this is a hospital-based casecontrol study, and, thus, needs external validation in other populations. Thirdly, our current analyses did not include all epidemiological factors, such as exposure to asbestos. Finally, this was a retrospectively designed study, and the sample size is relatively small; therefore, the results need to be validated by a large-scale and prospective design study.
Conclusion
In conclusion, MDM2-rs2279744 is associated with lung cancer risk in Northeastern Chinese population.
